// App-Quantinova.ai

139 : A Clinical Study Designed to Support a Demonstration of Interchangeability Between AVT02 and Reference Adalimumab (Humira®)

Researchers

Presenter

  • Steven Feldman

Principal Investigators

  • Heimo stroissnig

  • Richard Kay

  • Joanna Sobierska

  • Roshan Dias

  • Eric Guenzi

  • Hendrik Otto

  • Halimuniyazi Haliduola

  • Abid Sattar

  • Ruth Ruffieux

  • Matjaz Steijger

  • Fausto Berti

Medical Centers

  • Wake Forest School of Medicine, Winston-Salem, NC

  • Alvotech, Jülich, Germany

  • RK Statistics, Bakewell, United Kingdom

  • Alvotech, Zürich, Switzerland

  • UGA Biopharma, Bonn, Germany

  • Alvotech, London, United Kingdom

Locations

  • United States

  • Germany

  • United Kingdom

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

Disease

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • Randomized

  • Pharmacokinetics

  • Open Label

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved